Federal grant · project grant (b)
Rui: Expanding the Chemical Biology Toolbox for Studying Peptidoglycan Metabolism -with the Support of the Chemistry of Life Processes (CLP) Program in the Division of Chemistry, DR. Christopher Reid and His Students at Bryant University Are Studying the Development of Small Molecule Probes to Study Bacterial Cell Wall Metabolism. Most Bacteria Are Surrounded by a Carbohydrate-based Polymer Called Peptidoglycan. This Polymer Defines Cell Shape and Withstands the Outward Facing Osmotic Pressure. the Metabolism of Peptidoglycan Is a Highly Complex and Coordinated Process Between Synthetic and Degradative Processes. While Understanding of Peptidoglycan Biosynthesis Is Relatively Robust, There Are Significant Knowledge Gaps Regarding the Degradative Steps and How They Are Coordinated With Biosynthesis. to Address the Lack of Chemical Biology Methods to Study Peptidoglycan Degradation, This Proposal Looks to Expand on the Success of the N-acetylglucosaminidase Inhibitor Masarimycin in the Gram-positive Organism Bacillus Subtilis to Develop an Array of Masarimycin-based Chemical Biology Reagents for the Microbial Glycoscience Community. This Work Could Provide New Insights Into the Role Degradative Enzymes Such as N-acetylglucosaminidases Play in Cell Growth and Division. This Research Will Be Conducted With a Significant Number of Undergraduate Researchers. as Such, the Reid Laboratory Will Continuesto Contribute to the Training and Development of the Next Generation of Scientists. This Support Will Allow for the Reid Laboratory to Contribute to the Growth and Development of the Chemical Life Science Ecosystem in Rhode Island. Most Bacteria Are Surrounded by a Peptidoglycan Cell Wall That Defines Their Shape and Withstands the Outward Facing Osmotic Pressure. Peptidoglycan Metabolism Is a Highly Complex and Coordinated Process Between Synthetic and Degradative Enzymes. While Understanding of the Biosynthetic Steps Is Relatively Robust, Significant Knowledge Gaps Exist Regarding the Degradative Steps and How They Are Coordinated With Biosynthesis. to Address the Lack of Tools to Study Peptidoglycan Metabolism and Degradative Enzymes in Particular, the Reid Lab at Bryant University Has Developed the Small Molecule Probe, Masarimycin (mas), to Inhibit the Major Active N-acetylglucosaminidase Lytg From Bacillus Subtilis. Through This Proposal, the Reid Lab Seeks to Expand This Work by Developing New Glycosyl Triazole and Diamide Inhibitors of N-acetylglucosaminidases Against Representative Gram-negative, Positive, and Mycolicibacteria. Masarimycin Provides a Vehicle Through Which to Study the Differences in Peptidoglycan Metabolism and Regulation in Rod- and Coccoid-shaped Bacteria. to Achieve These Goals, the Reid Lab Will Pursue Three Objectives in Parallel. for the First Objective, Studies Will Build on Their Preliminary Identification of Glcnacase Diamide Inhibitors in B. Subtilis and S. Pneumoniae to Create a Second-generation Masarimycin Inhibitor With Potentially Improved Potency and Physical-chemical Properties. for the Second Objective, Preliminary Glycosyl-triazole and Diamide Leads Against Escherichia Coli and Mycolicibacterium Smegmatis Will Be Evaluated to Determine If These New Inhibitors Disrupt Cell Wall Metabolism in Gram-negative and Acid-fast Bacteria in the Same Manner as in Gram-positive Organisms. Finally, a Comparative Study Between B. Subtilis and S. Pneumoniae Will Be Performed, Using Masarimycin as a Probe, to Investigate the Differences in PG Metabolism Between Rod- and Coccoid-shaped Bacteria. the Proposed Work Could Open the Door for Masarimycin, and Diamide Inhibitors in General, to Serve as Valuable Chemical Biology Reagents for Studying PG Metabolism Across Key Bacterial Genera. This Project Is Jointly Funded by the Chemistry of Life Processes (CLP) Program and the Established Program to Stimulate Competitive Research (epscor). This Award Reflects NSF'S Statutory Mission and Has Been Deemed Worthy of Support Through Evaluation Using the Foundation's Intellectual Merit and Broader Impacts Review Criteria.- Subawards Are Not Planned for This Award.
Committed
$390,000
Paid out
$215.6K
55%
Committed, not yet paid
$174.4K
45%
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.